Mucins are highly expressed in many different human cancers and numero
us murine monoclonal antibodies (MAbs) to human mucins, particularly M
ucin I (MUCI), have been produced. However, no such antibodies to muri
ne mucin I (mucI) have been described and we now describe 6 different
antibodies produced to murine mud and to human MUCI cytoplasmic tail,
either by immunising rats, or mud o/o mice with synthetic peptides or
a fusion protein composed of glueathione-s-transferase (GST) linked to
the tandem repeat region of mucI. The antibodies to both the extracel
lular tandem repeat region and to the cytoplasmic tail were found to r
eact with mucin-containing murine tissues such as breast, stomach, col
on, ovary, kidney and pancreas, and the staining patterns were similar
to those found in humans. The reagents reacted specifically with mud
peptides and tissues; however, some cross reactivity with other mucin-
derived peptides was noted, particularly those containing the amino ac
id sequence TSS. Three different epitopes (TSS, TAVLSGTS and LSGTSSP)
of the M30, M70 and MFP25 MAbs were detected. Of interest was the find
ing that some of the antibodies reacted with murine lymphocytes; it wa
s not clear whether these reactions were due to mucin I on mouse lymph
ocytes (MUCI was considered to be absent from human lymphocyte), or du
e to cross reaction with a sialic adhesion molecule on lymphocytes. Th
e antibodies should prove valuable reagents when studying differentiat
ion and expression in murine glandular tissues and the ontogeny of muc
in-secreting tumours. (C) 1998 Wiley-Liss, Inc.